Prabhu, Priya Ramesh

Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study

Basu, P., Malvi, S. G., Joshi, S., Bhatla, N., Muwonge, R., Lucas, E., Verma, Y., Esmy, P. O., Poli, U. R. R., Shah, A., et al. (2021) · The Lancet Oncology

Cervical Cancer and HPV ResearchGenital Health and Disease

Cited by 272

Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study

Sankaranarayanan, R., Prabhu, P. R., Pawlita, M., Gheit, T., Bhatla, N., Muwonge, R., Nene, B. M., Esmy, P. O., Joshi, S., Poli, U. R. R., et al. (2016) · The Lancet Oncology

Cervical Cancer and HPV ResearchGenital Health and Disease

Cited by 242

Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study

Sankaranarayanan, R., Joshi, S., Muwonge, R., Esmy, P. O., Basu, P., Prabhu, P., Bhatla, N., Nene, B. M., Shaw, J., Poli, U. R. R., et al. (2018) · Vaccine

Cervical Cancer and HPV ResearchWomen's cancer prevention and management

Cited by 164

Status of cancer screening in India: An alarm signal from the National Family Health Survey (NFHS-5)

Gopika, M. G., Prabhu, P. R., & Thulaseedharan, J. V. (2022) · Journal of Family Medicine and Primary Care

Global Cancer Incidence and ScreeningWomen's cancer prevention and management

Cited by 62